Health

Alberta-based precision health company aims to deliver more precise testing for a leading cause of death among men while minimizing the risks of overdiagnosis.   Calgary – June 26, 2025 – Today, new investments into public-private R&D projects were announced as part of a new wave of new Genome Canada R&D investments supporting the Canadian

New investments are helping bring technology to patients, making it faster to test, diagnose, or treat health conditions, and improve the delivery of personalized medicine in Alberta and BC.   April 15, 2025 Calgary, Alberta – Genome Alberta and Genome British Columbia (Genome BC), with support from Government of Alberta and other key partners, are

Alberta to drive Canada’s competitive edge in health innovation using AI-powered genome sequencing data for more precise, preventative and cost-effective health care.   Calgary, Alberta – March 5, 2024 – Today, new investments into Alberta initiatives were announced as part of the Canadian Precision Health Initiative (CPHI) led by Genome Canada. This $81 million in

Genome Canada announces $6M investment for enhancing early-warning systems to promote public health and $2.88M for improving the treatment of autoimmune diseases.   From insights to impact we are putting genomics to work on promoting public health. Generating better information on pathogens and other influenza-like illnesses and diseases is vital for supporting decision making by